Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

62
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
62
Hazard Ratio01:12

Hazard Ratio

687
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
687
Hazard Rate01:11

Hazard Rate

474
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
474

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-linear association between tooth loss and cardiovascular diseases among middle-aged adults.

Journal of periodontology·2026
Same author

Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study.

Human vaccines & immunotherapeutics·2026
Same author

Associations of educational attainment with cardiometabolic markers and health behaviors: Evidence from the LIFE Study.

Journal of epidemiology·2026
Same author

Heart failure and renal outcomes with angiotensin receptor blockers compared with calcium channel blockers in patients with chronic kidney disease: a target trial emulation.

Heart (British Cardiac Society)·2026
Same author

Medical costs attributable to obesity and obesity-related health disorders in a Japanese population using JMDC claims database.

Journal of medical economics·2026
Same author

Angiotensin Receptor Blockers Versus Calcium Channel Blockers for First-Line Antihypertensive Therapy and Survival in Adults Aged 75 Years or Older.

Journal of the American Geriatrics Society·2026

Related Experiment Video

Updated: Mar 20, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K

Cost-Effectiveness Analysis of Safety-Engineered Devices.

Haruhisa Fukuda1, Kensuke Moriwaki2

  • 11Department of Health Care Administration and Management,Graduate School of Medical Sciences,Kyushu University,Fukuoka,Japan.

Infection Control and Hospital Epidemiology
|May 27, 2016
PubMed
Summary

Safety-engineered devices (SEDs) are not cost-effective for preventing needlestick injuries in Japanese hospitals. Government intervention is recommended to protect healthcare workers from bloodborne pathogen infections.

More Related Videos

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

790

Related Experiment Videos

Last Updated: Mar 20, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.0K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

790

Area of Science:

  • Healthcare economics
  • Occupational health and safety
  • Infectious disease prevention

Background:

  • Needlestick injuries pose a significant risk of bloodborne pathogen transmission to healthcare workers.
  • Safety-engineered devices (SEDs) were developed to mitigate these risks.
  • The cost-effectiveness of SEDs compared to traditional needle devices requires evaluation.

Purpose of the Study:

  • To estimate the cost-effectiveness of safety-engineered devices (SEDs) versus non-SEDs for various needle devices.
  • To analyze the economic impact of SEDs in preventing needlestick injuries in a healthcare setting.

Main Methods:

  • A decision-analytic model was developed to compare life-cycle costs and benefits of SEDs and non-SEDs.
  • Quantified direct medical costs per needlestick injury and injuries avoided.
  • Calculated incremental cost-effectiveness ratios (ICERs) for different needle types.

Main Results:

  • The ICERs for SED winged steel needles, intravenous catheter stylets, suture needles, and insulin pen needles were $2,633, $13,943, $1,792, and $1,269 per injury avoided, respectively.
  • Sensitivity analyses confirmed that SEDs did not yield cost savings under various parameter adjustments.
  • The study found no cost-effectiveness for SEDs in the Japanese healthcare context.

Conclusions:

  • The implementation of SED needle devices does not result in cost savings for hospitals.
  • Government intervention may be necessary to ensure systematic protection of healthcare workers against bloodborne pathogen infections in Japan.
  • Further research into cost-effective strategies for needlestick injury prevention is warranted.